APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antithrombotic Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antithrombotic Drugs Industry Growth and Trends Forecast to 2032

22 December 202599 pages

Choose your research edition.

Industry ResearchAntithrombotic Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Antithrombotic Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Antithrombotic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antithrombotic Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Antithrombotic Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Antithrombotic Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antithrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antithrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antithrombotic Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antithrombotic Drugs include Abbott laboratories, Bristol myers squibb pharma, Bristol-Myers Squibb, Pharmacia, Pliva, Watson laboratories, Zydus pharmaceuticals usa, Pfizer and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antithrombotic Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antithrombotic Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antithrombotic Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antithrombotic Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antithrombotic Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antithrombotic Drugs Market by Company

Abbott laboratories

Bristol myers squibb pharma

Bristol-Myers Squibb

Pharmacia

Pliva

Watson laboratories

Zydus pharmaceuticals usa

Pfizer

Sandoz

Antithrombotic Drugs Segment by Type

Rivaroxaban

Fondaparinux

Heparin

Apixaban

Edoxaban

Debigatran

Antithrombotic Drugs Segment by Application

Online Retailers

Hospital Pharmacies

Drug Stores

General Pharmacies

Antithrombotic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithrombotic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antithrombotic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithrombotic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antithrombotic Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antithrombotic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Rivaroxaban Table 2. Major Company of Fondaparinux Table 3. Major Company of Heparin Table 4. Major Company of Apixaban Table 5. Major Company of Edoxaban Table 6. Major Company of Debigatran Table 7. Global Antithrombotic Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Antithrombotic Drugs Sales by Type (2021-2026) & (k units) Table 9. Global Antithrombotic Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global Antithrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global Antithrombotic Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global Antithrombotic Drugs Price by Type (2021-2026) & (US$/unit) Table 13. Global Antithrombotic Drugs Sales by Type (2027-2032) & (k units) Table 14. Global Antithrombotic Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global Antithrombotic Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global Antithrombotic Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global Antithrombotic Drugs Price by Type (2027-2032) & (US$/unit) Table 18. North America Antithrombotic Drugs Sales by Type (2021-2026) & (k units) Table 19. North America Antithrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Antithrombotic Drugs Sales by Type (2021-2026) & (k units) Table 21. Europe Antithrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Antithrombotic Drugs Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific Antithrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Antithrombotic Drugs Sales by Type (2021-2026) & (k units) Table 25. Latin America Antithrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Antithrombotic Drugs Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa Antithrombotic Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Antithrombotic Drugs Industry Trends Table 29. Antithrombotic Drugs Industry Drivers Table 30. Antithrombotic Drugs Industry Opportunities and Challenges Table 31. Antithrombotic Drugs Industry Restraints Table 32. Global Antithrombotic Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Antithrombotic Drugs Revenue Market Share by Company (2021-2026) Table 34. Global Antithrombotic Drugs Sales by Company (2021-2026) & (k units) Table 35. Global Antithrombotic Drugs Sales Share by Company (2021-2026) Table 36. Global Antithrombotic Drugs Market Price by Company (2021-2026) & (US$/unit) Table 37. Global Antithrombotic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Antithrombotic Drugs Major Company Production Sites and Headquarters Table 39. Global Antithrombotic Drugs Company, Product Type & Application Table 40. Global Antithrombotic Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Antithrombotic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Antithrombotic Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Antithrombotic Drugs Sales by Region (2021-2026) & (k units) Table 45. Global Antithrombotic Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global Antithrombotic Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global Antithrombotic Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global Antithrombotic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 49. Global Antithrombotic Drugs Sales by Region (2027-2032) & (k units) Table 50. Global Antithrombotic Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global Antithrombotic Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global Antithrombotic Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global Antithrombotic Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 54. Global Antithrombotic Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Antithrombotic Drugs Sales by Application (2021-2026) & (k units) Table 56. Global Antithrombotic Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global Antithrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global Antithrombotic Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global Antithrombotic Drugs Price by Application (2021-2026) & (US$/unit) Table 60. Global Antithrombotic Drugs Sales by Application (2027-2032) & (k units) Table 61. Global Antithrombotic Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global Antithrombotic Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global Antithrombotic Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global Antithrombotic Drugs Price by Application (2027-2032) & (US$/unit) Table 65. North America Antithrombotic Drugs Sales by Application (2021-2026) & (k units) Table 66. North America Antithrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Antithrombotic Drugs Sales by Application (2021-2026) & (k units) Table 68. Europe Antithrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Antithrombotic Drugs Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific Antithrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Antithrombotic Drugs Sales by Application (2021-2026) & (k units) Table 72. Latin America Antithrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Antithrombotic Drugs Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa Antithrombotic Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Abbott laboratories Company Information Table 76. Abbott laboratories Business Overview Table 77. Abbott laboratories Antithrombotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Abbott laboratories Antithrombotic Drugs Product Portfolio Table 79. Abbott laboratories Recent Development Table 80. Bristol myers squibb pharma Company Information Table 81. Bristol myers squibb pharma Business Overview Table 82. Bristol myers squibb pharma Antithrombotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Bristol myers squibb pharma Antithrombotic Drugs Product Portfolio Table 84. Bristol myers squibb pharma Recent Development Table 85. Bristol-Myers Squibb Company Information Table 86. Bristol-Myers Squibb Business Overview Table 87. Bristol-Myers Squibb Antithrombotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Bristol-Myers Squibb Antithrombotic Drugs Product Portfolio Table 89. Bristol-Myers Squibb Recent Development Table 90. Pharmacia Company Information Table 91. Pharmacia Business Overview Table 92. Pharmacia Antithrombotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Pharmacia Antithrombotic Drugs Product Portfolio Table 94. Pharmacia Recent Development Table 95. Pliva Company Information Table 96. Pliva Business Overview Table 97. Pliva Antithrombotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Pliva Antithrombotic Drugs Product Portfolio Table 99. Pliva Recent Development Table 100. Watson laboratories Company Information Table 101. Watson laboratories Business Overview Table 102. Watson laboratories Antithrombotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Watson laboratories Antithrombotic Drugs Product Portfolio Table 104. Watson laboratories Recent Development Table 105. Zydus pharmaceuticals usa Company Information Table 106. Zydus pharmaceuticals usa Business Overview Table 107. Zydus pharmaceuticals usa Antithrombotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Zydus pharmaceuticals usa Antithrombotic Drugs Product Portfolio Table 109. Zydus pharmaceuticals usa Recent Development Table 110. Pfizer Company Information Table 111. Pfizer Business Overview Table 112. Pfizer Antithrombotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Pfizer Antithrombotic Drugs Product Portfolio Table 114. Pfizer Recent Development Table 115. Sandoz Company Information Table 116. Sandoz Business Overview Table 117. Sandoz Antithrombotic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Sandoz Antithrombotic Drugs Product Portfolio Table 119. Sandoz Recent Development Table 120. North America Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 121. North America Antithrombotic Drugs Sales by Country (2021-2026) & (k units) Table 122. North America Antithrombotic Drugs Sales Market Share by Country (2021-2026) Table 123. North America Antithrombotic Drugs Sales Forecast by Country (2027-2032) & (k units) Table 124. North America Antithrombotic Drugs Sales Market Share Forecast by Country (2027-2032) Table 125. North America Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. North America Antithrombotic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 127. North America Antithrombotic Drugs Market Share by Country (2021-2026) Table 128. North America Antithrombotic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. North America Antithrombotic Drugs Market Share Forecast by Country (2027-2032) Table 130. Europe Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 131. Europe Antithrombotic Drugs Sales by Country (2021-2026) & (k units) Table 132. Europe Antithrombotic Drugs Sales Market Share by Country (2021-2026) Table 133. Europe Antithrombotic Drugs Sales Forecast by Country (2027-2032) & (k units) Table 134. Europe Antithrombotic Drugs Sales Market Share Forecast by Country (2027-2032) Table 135. Europe Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Europe Antithrombotic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 137. Europe Antithrombotic Drugs Market Share by Country (2021-2026) Table 138. Europe Antithrombotic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Europe Antithrombotic Drugs Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Antithrombotic Drugs Sales by Country (2021-2026) & (k units) Table 142. Asia-Pacific Antithrombotic Drugs Sales Market Share by Country (2021-2026) Table 143. Asia-Pacific Antithrombotic Drugs Sales Forecast by Country (2027-2032) & (k units) Table 144. Asia-Pacific Antithrombotic Drugs Sales Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Antithrombotic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 147. Asia-Pacific Antithrombotic Drugs Market Share by Country (2021-2026) Table 148. Asia-Pacific Antithrombotic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Asia-Pacific Antithrombotic Drugs Market Share Forecast by Country (2027-2032) Table 150. Latin America Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 151. Latin America Antithrombotic Drugs Sales by Country (2021-2026) & (k units) Table 152. Latin America Antithrombotic Drugs Sales Market Share by Country (2021-2026) Table 153. Latin America Antithrombotic Drugs Sales Forecast by Country (2027-2032) & (k units) Table 154. Latin America Antithrombotic Drugs Sales Market Share Forecast by Country (2027-2032) Table 155. Latin America Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Latin America Antithrombotic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 157. Latin America Antithrombotic Drugs Market Share by Country (2021-2026) Table 158. Latin America Antithrombotic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Latin America Antithrombotic Drugs Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Antithrombotic Drugs Sales by Country (2021-2026) & (k units) Table 162. Middle East and Africa Antithrombotic Drugs Sales Market Share by Country (2021-2026) Table 163. Middle East and Africa Antithrombotic Drugs Sales Forecast by Country (2027-2032) & (k units) Table 164. Middle East and Africa Antithrombotic Drugs Sales Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Antithrombotic Drugs Market Size by Country (2021-2026) & (US$ Million) Table 167. Middle East and Africa Antithrombotic Drugs Market Share by Country (2021-2026) Table 168. Middle East and Africa Antithrombotic Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Middle East and Africa Antithrombotic Drugs Market Share Forecast by Country (2027-2032) Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Antithrombotic Drugs Distributors List Table 173. Antithrombotic Drugs Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Antithrombotic Drugs Image Figure 2. Global Antithrombotic Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antithrombotic Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Antithrombotic Drugs Sales (2021-2032) & (k units) Figure 5. Rivaroxaban Image Figure 6. Global Rivaroxaban Sales YoY Growth (2021-2032) & (k units) Figure 7. Fondaparinux Image Figure 8. Global Fondaparinux Sales YoY Growth (2021-2032) & (k units) Figure 9. Heparin Image Figure 10. Global Heparin Sales YoY Growth (2021-2032) & (k units) Figure 11. Apixaban Image Figure 12. Global Apixaban Sales YoY Growth (2021-2032) & (k units) Figure 13. Edoxaban Image Figure 14. Global Edoxaban Sales YoY Growth (2021-2032) & (k units) Figure 15. Debigatran Image Figure 16. Global Debigatran Sales YoY Growth (2021-2032) & (k units) Figure 17. Global Antithrombotic Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Antithrombotic Drugs Market Share by Type 2025 VS 2032 Figure 19. North America Antithrombotic Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America Antithrombotic Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe Antithrombotic Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe Antithrombotic Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Antithrombotic Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Antithrombotic Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America Antithrombotic Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Antithrombotic Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Antithrombotic Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Antithrombotic Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Antithrombotic Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Online Retailers Image Figure 32. Global Online Retailers Sales YoY Growth (2021-2032) & (k units) Figure 33. Hospital Pharmacies Image Figure 34. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 35. Drug Stores Image Figure 36. Global Drug Stores Sales YoY Growth (2021-2032) & (k units) Figure 37. General Pharmacies Image Figure 38. Global General Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Antithrombotic Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Antithrombotic Drugs Market Share by Application 2025 VS 2032 Figure 41. North America Antithrombotic Drugs Sales Market Share in Volume by Application in 2025 Figure 42. North America Antithrombotic Drugs Sales Market Share in Value by Application in 2025 Figure 43. Europe Antithrombotic Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Europe Antithrombotic Drugs Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Antithrombotic Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Antithrombotic Drugs Sales Market Share in Value by Application in 2025 Figure 47. Latin America Antithrombotic Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Antithrombotic Drugs Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Antithrombotic Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Antithrombotic Drugs Sales Market Share in Value by Application in 2025 Figure 51. North America Antithrombotic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Antithrombotic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Antithrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Antithrombotic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Antithrombotic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Antithrombotic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Antithrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Antithrombotic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Antithrombotic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Antithrombotic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Antithrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Antithrombotic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Antithrombotic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Antithrombotic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Antithrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Antithrombotic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Antithrombotic Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Antithrombotic Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Antithrombotic Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Antithrombotic Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Antithrombotic Drugs Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Antithrombotic Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Rivaroxaban
  • Fondaparinux
  • Heparin
  • Apixaban
  • Edoxaban
  • Debigatran
Applications
  • Online Retailers
  • Hospital Pharmacies
  • Drug Stores
  • General Pharmacies
Companies covered
  • Abbott laboratories
  • Bristol myers squibb pharma
  • Bristol-Myers Squibb
  • Pharmacia
  • Pliva
  • Watson laboratories
  • Zydus pharmaceuticals usa
  • Pfizer
  • Sandoz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antithrombotic Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antithrombotic Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antithrombotic Drugs Market by Type
  6. 1.3.1 Rivaroxaban
  7. 1.3.2 Fondaparinux
  8. 1.3.3 Heparin
  9. 1.3.4 Apixaban
  10. 1.3.5 Edoxaban
  11. 1.3.6 Debigatran
  12. 1.4 Global Antithrombotic Drugs Market Size by Type
  13. 1.4.1 Global Antithrombotic Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Antithrombotic Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Antithrombotic Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Antithrombotic Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Antithrombotic Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Antithrombotic Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Antithrombotic Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Antithrombotic Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antithrombotic Drugs Industry Trends
  2. 2.2 Antithrombotic Drugs Industry Drivers
  3. 2.3 Antithrombotic Drugs Industry Opportunities and Challenges
  4. 2.4 Antithrombotic Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antithrombotic Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Antithrombotic Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Antithrombotic Drugs Price (2021-2026)
  4. 3.4 Global Antithrombotic Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antithrombotic Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Antithrombotic Drugs Company, Product Type & Application
  7. 3.7 Global Antithrombotic Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antithrombotic Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antithrombotic Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antithrombotic Drugs Tier 1, Tier 2, and Tier 3
4 Antithrombotic Drugs Regional Status and Outlook
  1. 4.1 Global Antithrombotic Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antithrombotic Drugs Historic Market Size by Region
  3. 4.2.1 Global Antithrombotic Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antithrombotic Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antithrombotic Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antithrombotic Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Antithrombotic Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antithrombotic Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antithrombotic Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antithrombotic Drugs by Application
  1. 5.1 Antithrombotic Drugs Market by Application
  2. 5.1.1 Online Retailers
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Drug Stores
  5. 5.1.4 General Pharmacies
  6. 5.2 Global Antithrombotic Drugs Market Size by Application
  7. 5.2.1 Global Antithrombotic Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Antithrombotic Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Antithrombotic Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Antithrombotic Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Antithrombotic Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Antithrombotic Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Antithrombotic Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Antithrombotic Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott laboratories
  2. 6.1.1 Abbott laboratories Company Information
  3. 6.1.2 Abbott laboratories Business Overview
  4. 6.1.3 Abbott laboratories Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott laboratories Antithrombotic Drugs Product Portfolio
  6. 6.1.5 Abbott laboratories Recent Developments
  7. 6.2 Bristol myers squibb pharma
  8. 6.2.1 Bristol myers squibb pharma Company Information
  9. 6.2.2 Bristol myers squibb pharma Business Overview
  10. 6.2.3 Bristol myers squibb pharma Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol myers squibb pharma Antithrombotic Drugs Product Portfolio
  12. 6.2.5 Bristol myers squibb pharma Recent Developments
  13. 6.3 Bristol-Myers Squibb
  14. 6.3.1 Bristol-Myers Squibb Company Information
  15. 6.3.2 Bristol-Myers Squibb Business Overview
  16. 6.3.3 Bristol-Myers Squibb Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bristol-Myers Squibb Antithrombotic Drugs Product Portfolio
  18. 6.3.5 Bristol-Myers Squibb Recent Developments
  19. 6.4 Pharmacia
  20. 6.4.1 Pharmacia Company Information
  21. 6.4.2 Pharmacia Business Overview
  22. 6.4.3 Pharmacia Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pharmacia Antithrombotic Drugs Product Portfolio
  24. 6.4.5 Pharmacia Recent Developments
  25. 6.5 Pliva
  26. 6.5.1 Pliva Company Information
  27. 6.5.2 Pliva Business Overview
  28. 6.5.3 Pliva Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pliva Antithrombotic Drugs Product Portfolio
  30. 6.5.5 Pliva Recent Developments
  31. 6.6 Watson laboratories
  32. 6.6.1 Watson laboratories Company Information
  33. 6.6.2 Watson laboratories Business Overview
  34. 6.6.3 Watson laboratories Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Watson laboratories Antithrombotic Drugs Product Portfolio
  36. 6.6.5 Watson laboratories Recent Developments
  37. 6.7 Zydus pharmaceuticals usa
  38. 6.7.1 Zydus pharmaceuticals usa Company Information
  39. 6.7.2 Zydus pharmaceuticals usa Business Overview
  40. 6.7.3 Zydus pharmaceuticals usa Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Zydus pharmaceuticals usa Antithrombotic Drugs Product Portfolio
  42. 6.7.5 Zydus pharmaceuticals usa Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Antithrombotic Drugs Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Sandoz
  50. 6.9.1 Sandoz Company Information
  51. 6.9.2 Sandoz Business Overview
  52. 6.9.3 Sandoz Antithrombotic Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sandoz Antithrombotic Drugs Product Portfolio
  54. 6.9.5 Sandoz Recent Developments
7 North America by Country
  1. 7.1 North America Antithrombotic Drugs Sales by Country
  2. 7.1.1 North America Antithrombotic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antithrombotic Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Antithrombotic Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antithrombotic Drugs Market Size by Country
  6. 7.2.1 North America Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antithrombotic Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Antithrombotic Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antithrombotic Drugs Sales by Country
  2. 8.1.1 Europe Antithrombotic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antithrombotic Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Antithrombotic Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antithrombotic Drugs Market Size by Country
  6. 8.2.1 Europe Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antithrombotic Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antithrombotic Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antithrombotic Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Antithrombotic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antithrombotic Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antithrombotic Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antithrombotic Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antithrombotic Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antithrombotic Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antithrombotic Drugs Sales by Country
  2. 10.1.1 South America Antithrombotic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antithrombotic Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Antithrombotic Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antithrombotic Drugs Market Size by Country
  6. 10.2.1 South America Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antithrombotic Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Antithrombotic Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antithrombotic Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Antithrombotic Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antithrombotic Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antithrombotic Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antithrombotic Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Antithrombotic Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antithrombotic Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antithrombotic Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antithrombotic Drugs Value Chain Analysis
  2. 12.1.1 Antithrombotic Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antithrombotic Drugs Production Mode & Process
  7. 12.2 Antithrombotic Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antithrombotic Drugs Distributors
  10. 12.2.3 Antithrombotic Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst